<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04263636</url>
  </required_header>
  <id_info>
    <org_study_id>ES11/Th12/27-12-2019</org_study_id>
    <nct_id>NCT04263636</nct_id>
  </id_info>
  <brief_title>Luminous Efficiency Function V(λ)' of Patients That Underwent Pseudophakic Presbyopic Corrections</brief_title>
  <official_title>Introduction of a Modified Luminous Efficiency Function V(λ)' That Addresses Total Light Transmittance of Patients That Underwent Pseudophakic Presbyopic Corrections</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Democritus University of Thrace</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Democritus University of Thrace</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Primary objective of this study is to construct and validate a modified luminous efficiency
      function that addresses the distinct total eye light transmittance of patients that underwent
      bilateral pseudophakic presbyopic correction with trifocal intraocular lenses (IOLs)
      implantations.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Present study aims to identify in which degree multifocal IOLs modify eye light transmission
      and estimate the necessary task and environmental lighting adjustment in order to address
      lighting needs of patients following bilateral pseudophakic presbyopic corrections.
      Specifically, the aim of this study is to identify the minimum light intensity in which
      patients that underwent pseudophakic presbyopic correction with trifocal IOLs can reach their
      maximum visual acuity (measured when lights are at the 100% lighting level)
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 7, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>Minimum light intensity</measure>
    <time_frame>6 months postoperatively</time_frame>
    <description>Minimum light intensity in which participants reach their maximum critical visual acuity</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Critical Visual Acuity (CVA)</measure>
    <time_frame>6 months postoperatively</time_frame>
    <description>The print size of the optotype line fulfilling this criterion: all of the following lines are read at a time that is 1.96 times the standard deviation over the average reading time of the larger preceding lines. In clinical practice, the CVA is the minimum VA that can be read with the maximum possible speed.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Presbyopia</condition>
  <arm_group>
    <arm_group_label>Study group</arm_group_label>
    <description>Patients that underwent uneventful bilateral pseudophakic presbyopic correction with trifocal diffractive IOLs (PanOptix or PanOptix toric, Alcon Laboratories, Inc., Fort Worth, TX, USA)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>Patients of similar age without cataract that their crystalline lens has not been replaced.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Phacoemulsification with bilateral trifocal diffractive IOLs</intervention_name>
    <description>Uneventful bilateral pseudophakic presbyopic correction with trifocal diffractive IOLs</description>
    <arm_group_label>Study group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Presbyopic patients that underwent pseudophakic presbyopic correction with bilateral
        trifocal intraocular lenses implantation
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age between 45 to 70 years

        Exclusion Criteria:

          -  astigmatism &gt;1.00 diopters

          -  glaucoma

          -  former incisional eye surgery

          -  corneal or fundus disease

          -  diabetes mellitus

          -  autoimmune diseases

          -  neurological or psychiatric diseases

          -  posterior capsule rupture or lens misalignment

          -  postoperative uncorrected bilateral distant visual acuity &lt; 8/10.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Georgios Labiris, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Associate Professor</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eirini - Kanella Panagiotopoulou, MD</last_name>
    <phone>00306978730858</phone>
    <email>eipanagi@med.duth.gr</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital of Alexandroupolis</name>
      <address>
        <city>Alexandroupolis</city>
        <state>Evros</state>
        <zip>68100</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elefteria Halkia, MSc</last_name>
      <phone>00302551030405</phone>
      <email>echalkia@med.duth.gr</email>
    </contact>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 7, 2020</study_first_submitted>
  <study_first_submitted_qc>February 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 11, 2020</study_first_posted>
  <last_update_submitted>February 10, 2020</last_update_submitted>
  <last_update_submitted_qc>February 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Democritus University of Thrace</investigator_affiliation>
    <investigator_full_name>Georgios Labiris</investigator_full_name>
    <investigator_title>Associate Professor of Ophthalmology</investigator_title>
  </responsible_party>
  <keyword>pseudophakic presbyopic correction</keyword>
  <keyword>trifocal intraocular lens</keyword>
  <keyword>light intensity</keyword>
  <keyword>eye light transmittance</keyword>
  <keyword>light efficiency function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Presbyopia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

